Gain Therapeutics News

Latest Gain Therapeutics Stock News & GANX Headlines

Gain Therapeutics Reports Financial Results for Third Quarter 2026 and Provides Corporate Update

6 days ago | globenewswire.com

Gain Therapeutics Announces Late-Breakers and Poster Presentations at Upcoming Scientific Conferences

11 days ago | globenewswire.com

Gain Therapeutics to Attend the 2026 Maxim Growth Summit

a month ago | globenewswire.com

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

a month ago | globenewswire.com

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson's Disease and Movement Disorders

2 months ago | globenewswire.com

Gain Therapeutics (NASDAQ:GANX) versus Spyre Therapeutics (NASDAQ:SYRE) Head to Head Comparison

2 months ago | defenseworld.net

Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference

2 months ago | globenewswire.com

Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update

4 months ago | globenewswire.com

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson's Disease

5 months ago | globenewswire.com

Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

5 months ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

GANX

Gain Therapeutics

$ 1.04

-3.70%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Gain Therapeutics News

Latest Gain Therapeutics Stock News & GANX Headlines

Download App

People Also Watch

Explore our Tools